Type 2 diabetes mellitus (T2DM) is characterized by hyperglycemia due to persistent insulin
resistance, resulting in elevated blood glucose levels. Metformin is the most prescribed oral …

Majority of drugs are administered orally, yet their efficient absorption is often difficult to
achieve, with a low dose fraction reaching the blood compartment. Here, a microstirring pill …

Diabetes mellitus (DM) is a metabolic disorder that is one of the most common health
problems in the world, primarily type 2 DM (T2DM). Metformin (MTF), as the first-line …

Metformin (MTF) is a first-line drug in the treatment of type 2 diabetes mellitus. Delivered
through the oral route, MTF has several limitations, mainly due to the side effects in …

Background Driving the conventional drug in new applications has emerged as a research
hotspot for disease treatment. Metformin (MET) is conventionally used for the treatment of …

Controlling postprandial glucose levels for diabetic patients is critical to achieve the tight
glycemic control that decreases the risk for developing long-term micro-and macrovascular …

Metformin was originally derived from a botanical ancestry and became the most prescribed,
first-line therapy for Type 2 diabetes in most countries. In the last century, metformin was …

The delivery of macromolecular drugs via the gastrointestinal (GI) tract is challenging as
these drugs display low stability as well as poor absorption across the intestinal epithelium …

Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by persistent
hyperglycaemia with significant morbidity and mortality rates. Currently, metformin is a drug …

Diabetes is a metabolic disorder characterized by hyperglycemia due to defective insulin
secretion or its biological dysfunction. However, frequent subcutaneous injection of insulin …